Skip to main content
. 2017 Mar 1;34(1):72–80. doi: 10.4274/tjh.2016.0086

Table 3. Comparison of characteristic features of immune thrombocytopenia patients stratified by response status to rituximab therapy.

graphic file with name TJH-34-72-g3.jpg